Loading organizations...
Loading organizations...
Synthetic biology company producing cannabinoids for pharmaceuticals.
Octarine Bio has raised $13.7M across 4 funding rounds.
Octarine Bio has raised $13.7M in total across 4 funding rounds.
Octarine Bio has raised $13.7M in total across 4 funding rounds.
Octarine Bio's investors include Per Falholt, Steen Riisgaard, Edaphon, Oskare Capital, Jonas Ahm-Lundgren, Unconventional Ventures, The Footprint Firm, Thea Messel, Alexandre Ouimet-Storrs, Lene Gerlach.
Octarine Bio has raised $13.7M across 4 funding rounds. Most recently, it raised $5.9M Series A Extension in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 23, 2026 | $5.9M Series A Extension | Per Falholt, Steen Riisgaard, Edaphon, Oskare Capital, Jonas Ahm-Lundgren, Unconventional Ventures | |
| Nov 10, 2023 | $4.6M Other Equity | Oskare Capital, The Footprint Firm, Thea Messel | |
| Sep 21, 2022 | $2.0M Pre-Series A | Alexandre Ouimet-Storrs | |
| Mar 11, 2021 | $1.2M Seed Extension | Alexandre Ouimet-Storrs, Lene Gerlach |